CA4-05: Electronic Health Record Phenotyping to Define Rate of Extreme Weight Gain Associated with the Use of 2nd/3rd Generation Antipsychotic Medications

BACKGROUND/AIMS: Weight gain is an undesirable side effect of treatment with 2nd/3rd generation antipsychotic drugs which may have genetic determinants. A number of candidate genes have been analyzed but no genome-wide association studies (GWAS) have yet been reported. The purpose of this study was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Wood, G. Craig, Arterburn, David, Westbrook, Emily, Theis, Kay, Boscarino, Joseph, Rukstalis, Margaret, Still, Christopher, Gerhard, Glenn
Formato: Artigo
Idioma:Inglês
Publicado em: Marshfield Clinic 2012
Assuntos:
Selected Abstracts-HMORN 2012: Obesity
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3421302/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2012.1100.ca4-05
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados